Risk factors of acromial and scapular spine stress fractures differ by indication: a study by the ASES Complications of Reverse Shoulder Arthroplasty Multicenter Research Group.


Journal

Journal of shoulder and elbow surgery
ISSN: 1532-6500
Titre abrégé: J Shoulder Elbow Surg
Pays: United States
ID NLM: 9206499

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 08 02 2023
revised: 20 04 2023
accepted: 06 05 2023
medline: 14 11 2023
pubmed: 18 6 2023
entrez: 17 6 2023
Statut: ppublish

Résumé

Both patient and implant related variables have been implicated in the incidence of acromial (ASF) and scapular spine fractures (SSF) following reverse shoulder arthroplasty (RSA); however, previous studies have not characterized nor differentiated risk profiles for varying indications including primary glenohumeral arthritis with intact rotator cuff (GHOA), rotator cuff arthropathy (CTA), and massive irreparable rotator cuff tear (MCT). The purpose of this study was to determine patient factors predictive of cumulative ASF/SSF risk for varying preoperative diagnosis and rotator cuff status. Patients consecutively receiving RSA between January 2013 and June 2019 from 15 institutions comprising 24 members of the American Shoulder and Elbow Surgeons (ASES) with primary, preoperative diagnoses of GHOA, CTA and MCT were included for study. Inclusion criteria, definitions, and inclusion of patient factors in a multivariate model to predict cumulative risk of ASF/SSF were determined through an iterative Delphi process. The CTA and MCT groups were combined for analysis. Consensus was defined as greater than 75% agreement amongst contributors. Only ASF/SSF confirmed by clinical and radiographic correlation were included for analysis. Our study cohort included 4764 patients with preoperative diagnoses of GHOA, CTA, or MCT with minimum follow-up of 3 months (range: 3-84). The incidence of cumulative stress fracture was 4.1% (n = 196). The incidence of stress fracture in the GHOA cohort was 2.1% (n = 34/1637) compared to 5.2% (n = 162/3127) (P < .001) in the CTA/MCT cohort. Presence of inflammatory arthritis (odds ratio [OR] 2.90, 95% confidence interval [CI] 1.08-7.78; P = .035) was the sole predictive factor of stress fractures in GHOA, compared with inflammatory arthritis (OR 1.86, 95% CI 1.19-2.89; P = .016), female sex (OR 1.81, 95% CI 1.20-2.72; P = .007), and osteoporosis (OR 1.56, 95% CI 1.02-2.37; P = .003) in the CTA/MCT cohort. Preoperative diagnosis of GHOA has a different risk profile for developing stress fractures after RSA than patients with CTA/MCT. Though rotator cuff integrity is likely protective against ASF/SSF, approximately 1/46 patients receiving RSA with primary GHOA will have this complication, primarily influenced by a history of inflammatory arthritis. Understanding risk profiles of patients undergoing RSA by varying diagnosis is important in counseling, expectation management, and treatment by surgeons.

Sections du résumé

BACKGROUND BACKGROUND
Both patient and implant related variables have been implicated in the incidence of acromial (ASF) and scapular spine fractures (SSF) following reverse shoulder arthroplasty (RSA); however, previous studies have not characterized nor differentiated risk profiles for varying indications including primary glenohumeral arthritis with intact rotator cuff (GHOA), rotator cuff arthropathy (CTA), and massive irreparable rotator cuff tear (MCT). The purpose of this study was to determine patient factors predictive of cumulative ASF/SSF risk for varying preoperative diagnosis and rotator cuff status.
METHODS METHODS
Patients consecutively receiving RSA between January 2013 and June 2019 from 15 institutions comprising 24 members of the American Shoulder and Elbow Surgeons (ASES) with primary, preoperative diagnoses of GHOA, CTA and MCT were included for study. Inclusion criteria, definitions, and inclusion of patient factors in a multivariate model to predict cumulative risk of ASF/SSF were determined through an iterative Delphi process. The CTA and MCT groups were combined for analysis. Consensus was defined as greater than 75% agreement amongst contributors. Only ASF/SSF confirmed by clinical and radiographic correlation were included for analysis.
RESULTS RESULTS
Our study cohort included 4764 patients with preoperative diagnoses of GHOA, CTA, or MCT with minimum follow-up of 3 months (range: 3-84). The incidence of cumulative stress fracture was 4.1% (n = 196). The incidence of stress fracture in the GHOA cohort was 2.1% (n = 34/1637) compared to 5.2% (n = 162/3127) (P < .001) in the CTA/MCT cohort. Presence of inflammatory arthritis (odds ratio [OR] 2.90, 95% confidence interval [CI] 1.08-7.78; P = .035) was the sole predictive factor of stress fractures in GHOA, compared with inflammatory arthritis (OR 1.86, 95% CI 1.19-2.89; P = .016), female sex (OR 1.81, 95% CI 1.20-2.72; P = .007), and osteoporosis (OR 1.56, 95% CI 1.02-2.37; P = .003) in the CTA/MCT cohort.
CONCLUSION CONCLUSIONS
Preoperative diagnosis of GHOA has a different risk profile for developing stress fractures after RSA than patients with CTA/MCT. Though rotator cuff integrity is likely protective against ASF/SSF, approximately 1/46 patients receiving RSA with primary GHOA will have this complication, primarily influenced by a history of inflammatory arthritis. Understanding risk profiles of patients undergoing RSA by varying diagnosis is important in counseling, expectation management, and treatment by surgeons.

Identifiants

pubmed: 37330167
pii: S1058-2746(23)00452-4
doi: 10.1016/j.jse.2023.05.015
pii:
doi:

Types de publication

Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2483-2492

Informations de copyright

Copyright © 2023 Journal of Shoulder and Elbow Surgery Board of Trustees. Published by Elsevier Inc. All rights reserved.

Auteurs

Ryan Lohre (R)

Department of Orthopaedic Surgery, Harvard Medical School, Massachusetts General Hospital, Boston Shoulder Institute, Boston, MA, USA.

Daniel P Swanson (DP)

Department of Orthopaedic Surgery, New England Baptist Hospital, Boston, MA, USA.

Kuhan A Mahendraraj (KA)

Department of Orthopaedic Surgery, New England Baptist Hospital, Boston, MA, USA.

Randa Elmallah (R)

Department of Orthopaedic Surgery, New England Baptist Hospital, Boston, MA, USA.

Evan A Glass (EA)

Department of Orthopaedic Surgery, New England Baptist Hospital, Boston, MA, USA.

Warren R Dunn (WR)

Fondren Orthopaedic Group, Orthopaedic Surgery, Houston, TX, USA.

Dylan J Cannon (DJ)

Holy Cross Orthopedic Institute, Fort Lauderdale, FL, USA.

Lisa Gm Friedman (LG)

Midwest Orthopaedics at Rush, Rush University Medical Center, Chicago, IL, USA.

Jaina A Gaudette (JA)

Midwest Orthopaedics at Rush, Rush University Medical Center, Chicago, IL, USA.

John Green (J)

Department of Orthopaedic Surgery, Saint Louis University School of Medicine, St Louis, MO, USA.

Lauren Grobaty (L)

Department of Orthopaedic Surgery, Cleveland Clinic, Cleveland, OH, USA.

Michael Gutman (M)

Rothman Orthopaedic Institute, Philadelphia, PA, USA.

Jaquelyn Kakalecik (J)

Department of Orthopaedic Surgery and Sports Medicine, University of Florida College of Medicine, Gainesville, FL, USA.

Michael A Kloby (MA)

University of Cincinnati College of Medicine, Cincinnati, OH, USA.

Elliot N Konrade (EN)

University of Tennessee Health Science Center-Campbell Clinic Department of Orthopaedic Surgery & Biomedical Engineering, Memphis, TN, USA.

Margaret C Knack (MC)

University of Tennessee Health Science Center-Campbell Clinic Department of Orthopaedic Surgery & Biomedical Engineering, Memphis, TN, USA.

Amy Loveland (A)

MedStar Union Memorial Hospital, Baltimore, MD, USA.

Joshua I Mathew (JI)

Hospital for Special Surgery, New York, NY, USA.

Luke Myhre (L)

University of Utah School of Medicine, Salt Lake City, UT, USA.

Jacob Nyfeler (J)

University of Utah School of Medicine, Salt Lake City, UT, USA.

Doug E Parsell (DE)

Mississippi Sports Medicine and Orthopaedic Surgery, Jackson, MS, USA.

Marissa Pazik (M)

Department of Orthopaedic Surgery and Sports Medicine, University of Florida College of Medicine, Gainesville, FL, USA.

Teja S Polisetty (TS)

Holy Cross Orthopedic Institute, Fort Lauderdale, FL, USA.

Padmavathi Ponnuru (P)

Penn State Bone and Joint Institute, Hershey, PA, USA.

Karch M Smith (KM)

University of Utah School of Medicine, Salt Lake City, UT, USA.

Katherine A Sprengel (KA)

Midwest Orthopaedics at Rush, Rush University Medical Center, Chicago, IL, USA.

Ocean Thakar (O)

MedStar Union Memorial Hospital, Baltimore, MD, USA.

Lacie Turnbull (L)

Department of Orthopaedic Surgery and Sports Medicine, University of Florida College of Medicine, Gainesville, FL, USA.

Alayna Vaughan (A)

Rothman Orthopaedic Institute, Philadelphia, PA, USA.

John C Wheelwright (JC)

University of Utah School of Medicine, Salt Lake City, UT, USA.

Joseph Abboud (J)

Rothman Orthopaedic Institute, Philadelphia, PA, USA.

April Armstrong (A)

Penn State Bone and Joint Institute, Hershey, PA, USA.

Luke Austin (L)

Rothman Orthopaedic Institute, Philadelphia, PA, USA.

Tyler Brolin (T)

University of Tennessee Health Science Center-Campbell Clinic Department of Orthopaedic Surgery & Biomedical Engineering, Memphis, TN, USA.

Vahid Entezari (V)

Department of Orthopaedic Surgery, Cleveland Clinic, Cleveland, OH, USA.

Grant E Garrigues (GE)

Midwest Orthopaedics at Rush, Rush University Medical Center, Chicago, IL, USA.

Brian Grawe (B)

University of Cincinnati College of Medicine, Cincinnati, OH, USA.

Lawrence V Gulotta (LV)

Hospital for Special Surgery, New York, NY, USA.

Rhett Hobgood (R)

Mississippi Sports Medicine and Orthopaedic Surgery, Jackson, MS, USA.

John G Horneff (JG)

University of Pennsylvania, Philadelphia, PA, USA.

Joseph Iannotti (J)

Department of Orthopaedic Surgery, Cleveland Clinic, Cleveland, OH, USA.

Michael Khazzam (M)

UT Southwestern Medical Center, Dallas, TX, USA.

Joseph J King (JJ)

Department of Orthopaedic Surgery and Sports Medicine, University of Florida College of Medicine, Gainesville, FL, USA.

Jacob M Kirsch (JM)

Department of Orthopaedic Surgery, New England Baptist Hospital, Boston, MA, USA.

Jonathan C Levy (JC)

Levy Shoulder Center at Paley Orthopedic and Spine Institute, Boca Raton, FL, USA.

Anand Murthi (A)

MedStar Union Memorial Hospital, Baltimore, MD, USA.

Surena Namdari (S)

Rothman Orthopaedic Institute, Philadelphia, PA, USA.

Gregory P Nicholson (GP)

Midwest Orthopaedics at Rush, Rush University Medical Center, Chicago, IL, USA.

Randall J Otto (RJ)

Department of Orthopaedic Surgery, Saint Louis University School of Medicine, St Louis, MO, USA.

Eric T Ricchetti (ET)

Department of Orthopaedic Surgery, Cleveland Clinic, Cleveland, OH, USA.

Robert Tashjian (R)

University of Utah School of Medicine, Salt Lake City, UT, USA.

Thomas Throckmorton (T)

University of Tennessee Health Science Center-Campbell Clinic Department of Orthopaedic Surgery & Biomedical Engineering, Memphis, TN, USA.

Thomas Wright (T)

Department of Orthopaedic Surgery and Sports Medicine, University of Florida College of Medicine, Gainesville, FL, USA.

Andrew Jawa (A)

Department of Orthopaedic Surgery, New England Baptist Hospital, Boston, MA, USA. Electronic address: andrewjawa@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH